NEOMYCIN Drug Patent Profile

Which patents cover Neomycin, and when can generic versions of Neomycin launch?

Neomycin is a drug marketed by Pharmafair, Watson Labs, Xgen Pharms, Bausch And Lomb, Padagis Us, Sciegen Pharms Inc, Alcon Pharms Ltd, Ipharm, Amneal, Sandoz, Saptalis Pharms, Aarxion Anda Hlding, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Pharmobedient, Roxane, Teva, Fougera, and Pharmaderm. and is included in forty-four NDAs.

The generic ingredient in NEOMYCIN is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.

Summary for NEOMYCIN

US Patents:	0
Applicants:	21
NDAs:	44
Drug Prices:	Drug price information for NEOMYCIN
DailyMed Link:	NEOMYCIN at DailyMed

See drug prices for NEOMYCIN

US Patents and Regulatory Information for NEOMYCIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmaderm	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	neomycin sulfate; triamcinolone acetonide	CREAM;TOPICAL	062595-001	Jul 21, 1986		DISCN	No	No
Sandoz	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	061586-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Lannett	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	060607-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Teva	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	060304-001	Approved Prior to Jan 1, 1982	AA	RX	No	Yes
Lilly	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	060385-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmafair	NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE	bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate	OINTMENT;TOPICAL	062381-001	Sep 6, 1985		DISCN	No	No